文献速递复苏、休克与脓毒症心脑血管急症

院外心脏骤停中静脉注射肾上腺素的时机

Timing of Intravenous Epinephrine Administration During Out-of-Hospital Cardiac Arrest.
PubMed 文献 · Shock · 2021-01-01
一句话结论OHCA患者静脉肾上腺素每延迟1分钟,1个月神经功能良好生存率下降(校正OR 0.91),延迟>20分钟较≤20分钟生存率显著降低(RR 0.34,NNT 69)。

该研究基于日本全国性OHCA登记数据,纳入2011-2017年院前由急救人员给予静脉肾上腺素的成人OHCA患者119,946例。多变量logistic回归显示,首次给药时间每延迟1分钟,1个月神经功能良好生存率降低(校正OR 0.91,95%CI 0.90-0.92)。倾向性评分匹配分析显示,延迟(>20分钟)给药较早期(≤20分钟)给药1个月神经功能良好生存率显著降低(0.8% vs 2.2%;RR 0.34,95%CI 0.30-0.39;NNT 69)。结论提示延迟肾上腺素给药与OHCA后不良神经结局相关。

要点

  • 成人OHCA院前静脉肾上腺素给药每延迟1分钟,1个月神经功能良好生存率下降(校正OR 0.91,95%CI 0.90-0.92)。
  • 延迟(>20分钟)给药较早期(≤20分钟)给药1个月神经功能良好生存率显著降低(0.8% vs 2.2%;RR 0.34,95%CI 0.30-0.39)。
  • 早期(≤20分钟)给药组1个月神经功能良好生存率为2.2%(959/42,804),延迟组为0.8%(330/42,804)。
  • NNT=69,即每早期给药69例可多1例1个月神经功能良好生存。
  • 研究为观察性登记分析,仅提示时间与结局的相关性,不能确定因果关系。

适用人群与场景

  • 日本2011-2017年全国性OHCA登记中,成人院外心脏骤停且由急救人员在院前给予静脉肾上腺素的患者(n=119,946;平均年龄75.2岁,男性61.4%)。

诊断标准与关键阈值

  • 原文未提及诊断标准或评分界值;仅将早期定义为首次肾上腺素给药时间≤20分钟,延迟定义为>20分钟。

处置流程与药物剂量

  • 原文未提及具体给药剂量、频次或目标值;仅描述院前由急救人员给予静脉肾上腺素,并分析首次给药时间与结局的关联。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于日本政府主导的全国性人群登记数据的回顾性队列分析;样本量119,946例;无多中心干预对照。
  • 主要终点:1个月神经功能良好生存;多变量校正后,首次肾上腺素给药时间每延迟1分钟,OR 0.91(95%CI 0.90-0.92)。
  • 倾向性评分匹配队列:延迟(>20分钟)vs 早期(≤20分钟)给药,1个月神经功能良好生存率0.8% vs 2.2%(RR 0.34,95%CI 0.30-0.39;NNT 69)。
  • 原文未提及关键次要终点和不良事件的具体结果。

证据类型、等级与局限

  • 证据类型:回顾性全国登记队列研究(观察性)。
  • 局限:原文未明确给出证据等级或推荐强度;设计为观察性研究,存在混杂可能,仅能提示相关性而非因果关系。

对床旁实践的改变

  • 在院前OHCA成人患者中,应尽可能缩短首次静脉肾上腺素给药时间,避免延迟超过20分钟,以可能改善1个月神经功能良好生存。
  • 该证据来自观察性登记分析,不能直接推断因果;不适用于未接受静脉肾上腺素的患者或院内心脏骤停。
  • 常见陷阱:将时间关联误认为因果,或忽略混杂因素(如复苏质量、初始心律等)对结局的影响。

指南或共识出处

  • 原文未提及指南或共识名称;研究数据来源为日本政府主导的全国性OHCA登记(2011-2017年)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Current guidelines for cardiopulmonary resuscitation recommend that standard dose of epinephrine be administered every 3 to 5 min during cardiac arrest. However, there is controversy about the association between timing of epinephrine administration and outcomes after out-of-hospital cardiac arrest (OHCA). This study aimed to determine whether the timing of intravenous epinephrine administration is associated with outcomes after OHCA.

METHODS: We analyzed Japanese government-led nationwide population-based registry data for OHCA. Adult OHCA patients who received intravenous epinephrine by emergency medical service personnel in the prehospital setting from 2011 to 2017 were included. Multivariable logistic regression models were used to assess the associations between time to first epinephrine administration and outcomes after OHCA. Subsequently, associations between early (≤20 min) versus delayed (>20 min) epinephrine administration and outcomes after OHCA were examined using propensity score-matched analyses. The primary outcome was 1-month neurologically favorable survival.

RESULTS: A total of 119,946 patients (mean [SD] age, 75.2 [14.8] years; 61.4% male) were included. The median time to epinephrine was 23 min (interquartile range, 19-29). Longer time to epinephrine was significantly associated with a decreased chance of 1-month neurologically favorable survival (multivariable adjusted OR per minute delay, 0.91 [95% CI, 0.90-0.92]). In the propensity score-matched cohort, when compared with early (≤20 min) epinephrine, delayed (>20 min) epinephrine was associated with a decreased chance of 1-month neurologically favorable survival (959/42,804 [2.2%] vs. 330/42,804 [0.8%]; RR, 0.34; 95% CI, 0.30-0.39; NNT, 69).

CONCLUSIONS: Delay in epinephrine administration was associated with a decreased chance of 1-month neurologically favorable survival among patients with OHCA.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Fukuda T, Ohashi-Fukuda N, Inokuchi R, et al. Timing of Intravenous Epinephrine Administration During Out-of-Hospital Cardiac Arrest. Shock. 2021. PMID: 33481550. doi:10.1097/SHK.0000000000001731

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。